Jón Thorkell Einarsson

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden

Jón Thorkell Einarsson, Minna Willim, Sofia Ernestam et al. · Lara D. Veeken · 2018 · 64 citations

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 44 citations · Full text

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies

Jón Thorkell Einarsson, M Evert, Pierre Geborek et al. · Clinical Rheumatology · 2017 · 39 citations · Full text

Middle lobe syndrome: a nationwide study on clinicopathological features and surgical treatment

Jón Thorkell Einarsson, Jónas Geir Einarsson, Helgi J. Ísaksson et al. · The Clinical Respiratory Journal · 2009 · 36 citations

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Per Nived, Göran Jönsson, Bo Settergren et al. · Arthritis Research & Therapy · 2020 · 24 citations · Full text